April 1, 2024
Sponsored by Trialize
In the realm of clinical trials, efficient data management and monitoring are crucial yet often hampered by outdated and time-consuming …
The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …
We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Introduction Glioblastomas (GBM) are devastating brain tumors and rank as one of the most aggressive human cancers with a median …
Oct. 7, 2022
Sponsored by Arctoris
Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …
There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …
July 21, 2022
Sponsored by Cyclica
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive …
Sponsored by Biocompare.com Every marketer feels pressure to demonstrate results for their marketing spend. Executives in the life sciences industry …
